Nautilus Biotechnology Stock Price on February 20, 2024
| NAUT Stock | USD 2.24 0.06 2.61% |
Below is the normalized historical share price chart for Nautilus Biotechnology extending back to August 07, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Nautilus Biotechnology stands at 2.24, as last reported on the 30th of November, with the highest price reaching 2.44 and the lowest price hitting 2.24 during the day.
If you're considering investing in Nautilus Stock, it is important to understand the factors that can impact its price. Nautilus Biotechnology has Sharpe Ratio of -0.0304, which conveys that the firm had a -0.0304% return per unit of risk over the last 3 months. Nautilus Biotechnology exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nautilus Biotechnology's Standard Deviation of 3.9, mean deviation of 3.08, and Risk Adjusted Performance of (0.02) to check out the risk estimate we provide.
Total Stockholder Equity is likely to drop to about 171.8 M in 2024. Common Stock Total Equity is likely to drop to about 13.1 K in 2024. At this time, Nautilus Biotechnology's Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 2.12 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (7.58) in 2024. Nautilus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of June 2021 | 200 Day MA 2.6245 | 50 Day MA 2.6687 | Beta 1.036 |
Nautilus |
Sharpe Ratio = -0.0304
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NAUT |
Estimated Market Risk
| 3.98 actual daily | 35 65% of assets are more volatile |
Expected Return
| -0.12 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Nautilus Biotechnology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nautilus Biotechnology by adding Nautilus Biotechnology to a well-diversified portfolio.
Price Book 1.2925 | Book Value 1.779 | Enterprise Value 179.8 M | Enterprise Value Ebitda (2.00) | Shares Float 41.9 M |
Related Headline
Kymera Therapeutics Headline on 20th of February 2024
Disposition of 615 shares by Albers Jeffrey W. of Kymera The... by Albers Jeffrey W.
Filed transaction by Kymera Therapeutics Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Nautilus Biotechnology Valuation on February 20, 2024
It is possible to determine the worth of Nautilus Biotechnology on a given historical date. On February 20, 2024 Nautilus was worth 2.77 at the beginning of the trading date compared to the closed value of 2.74. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Nautilus Biotechnology stock. Still, in general, we apply an absolute valuation method to find Nautilus Biotechnology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nautilus Biotechnology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Nautilus Biotechnology's related companies.
| Open | High | Low | Close | Volume | |
| 3.06 | 3.08 | 2.80 | 2.83 | 68,709 | |
02/20/2024 | 2.77 | 2.83 | 2.70 | 2.74 | 58,346 |
| 2.78 | 2.84 | 2.69 | 2.77 | 43,783 |
| Backtest Nautilus Biotechnology | | | Nautilus Biotechnology History | | | Nautilus Biotechnology Valuation | Previous | Next |
Nautilus Biotechnology Trading Date Momentum on February 20, 2024
| On February 21 2024 Nautilus Biotechnology was traded for 2.77 at the closing time. The top price for the day was 2.84 and the lowest listed price was 2.69 . The trading volume for the day was 43.8 K. The trading history from February 21, 2024 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 1.09% . The trading delta at closing time against the current closing price is 1.09% . |
Nautilus Biotechnology Fundamentals Correlations and Trends
By evaluating Nautilus Biotechnology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Nautilus Biotechnology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Nautilus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Nautilus Biotechnology Stock history
Nautilus Biotechnology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Nautilus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Nautilus Biotechnology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Nautilus Biotechnology stock prices may prove useful in developing a viable investing in Nautilus Biotechnology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 124.9 M | 69.4 M | |
| Net Loss | -52.1 M | -54.7 M |
Nautilus Biotechnology Quarterly Net Working Capital |
|
Nautilus Biotechnology Stock Technical Analysis
Nautilus Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Nautilus Biotechnology Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Nautilus Biotechnology cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Nautilus Biotechnology November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Nautilus Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nautilus Biotechnology shares will generate the highest return on investment. By undertsting and applying Nautilus Biotechnology stock market strength indicators, traders can identify Nautilus Biotechnology entry and exit signals to maximize returns
Nautilus Biotechnology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Nautilus Biotechnology's price direction in advance. Along with the technical and fundamental analysis of Nautilus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Nautilus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.48) | |||
| Total Risk Alpha | (0.82) | |||
| Treynor Ratio | (0.07) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Nautilus Stock Analysis
When running Nautilus Biotechnology's price analysis, check to measure Nautilus Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nautilus Biotechnology is operating at the current time. Most of Nautilus Biotechnology's value examination focuses on studying past and present price action to predict the probability of Nautilus Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nautilus Biotechnology's price. Additionally, you may evaluate how the addition of Nautilus Biotechnology to your portfolios can decrease your overall portfolio volatility.